-
1 . Academic Journal
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
- 저자
- by Reid, Christopher; Schlaich, Markus; Katz, Ivor; Ajani, Andrew; Biswas, Sinjini, et al.
- 소스
- In The Lancet 3-9 December 2022 400(10367):1927-1937
-
7 . Periodical
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
- 저자
- by Schlaich, Markus P; Bellet, Marc; Weber, Michael A; Danaietash, Parisa; Bakris, George L, et al.
- 소스
- The Lancet; December 2022, Vol. 400 Issue: 10367 p1927-1937, 11p
-
7 . Periodical
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
- 저자
- by Bhatt, Deepak L; Steg, Philippe Gabriel; Mehta, Shamir R; Leiter, Lawrence A; Simon, Tabassome, et al.
- 소스
- The Lancet; September-October 2019, Vol. 394 Issue: 10204 p1169-1180, 12p